Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins

American Journal of Cardiology

Volumn 112, Issue 11, 2013, Pages 1770-1777

  Kim, Juyong Brian ^a   Hama, Susan ^a   Hough, Greg ^a   Navab, Mohamad ^a   Fogelman, Alan M ^a   Maclellan, W Robb ^a,b   Horwich, Tamara B ^a,b   Fonarow, Gregg C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIOXIDANT; APOLIPOPROTEIN A1; ARACHIDONIC ACID; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A; TRIACYLGLYCEROL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OXIDATION; PRIORITY JOURNAL;

ADULT; AGED; ARACHIDONIC ACID; ARYLDIALKYLPHOSPHATASE; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; LINOLEIC ACID; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; SERUM AMYLOID A PROTEIN;

EID: 84888007863     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.07.045     Document Type: Article

References (20)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, T.M. Brown, M.R. Carnethon, S. Dai, G. de Simone, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, K.J. Greenlund, S.M. Hailpern, J.A. Heit, P.M. Ho, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, M.M. McDermott, J.B. Meigs, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, W.D. Rosamond, P.D. Sorlie, R.S. Stafford, T.N. Turan, M.B. Turner, N.D. Wong, and J. Wylie-Rosett Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. M. Jessup, and S. Brozena Heart failure N Engl J Med 348 2003 2007 2018
3. J.G. Cleland, S. Chattopadhyay, A. Khand, T. Houghton, and G.C. Kaye Prevalence and incidence of arrhythmias and sudden death in heart failure Heart Fail Rev 7 2002 229 242
4. A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, and D.L. Mann Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) Circulation 103 2001 2055 2059
5. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD) J Am Coll Cardiol 27 1996 1201 1206
6. H. Bahrami, D.A. Bluemke, R. Kronmal, A.G. Bertoni, D.M. Lloyd-Jones, E. Shahar, M. Szklo, and J.A. Lima Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 51 2008 1775 1783
7. I.S. Anand, R. Latini, V.G. Florea, M.A. Kuskowski, T. Rector, S. Masson, S. Signorini, P. Mocarelli, A. Hester, R. Glazer, and J.N. Cohn C-reactive protein in heart failure: prognostic value and the effect of valsartan Circulation 112 2005 1428 1434
8. D.L. Mann Targeted anticytokine therapy and the failing heart Am J Cardiol 95 2005 9C 16C
9. M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, S.T. Reddy, and A.M. Fogelman A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids J Lipid Res 42 2001 1308 1317
10. B.J. Van Lenten, A.C. Wagner, C.L. Jung, P. Ruchala, A.J. Waring, R.I. Lehrer, A.D. Watson, S. Hama, M. Navab, G.M. Anantharamaiah, and A.M. Fogelman Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I J Lipid Res 49 2008 2302 2311
11. M. Navab, S.Y. Hama, C.J. Cooke, G.M. Anantharamaiah, M. Chaddha, L. Jin, G. Subbanagounder, K.F. Faull, S.T. Reddy, N.E. Miller, and A.M. Fogelman Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1 J Lipid Res 41 2000 1481 1494
12. N.D. Vaziri, H. Moradi, M.V. Pahl, A.M. Fogelman, and M. Navab In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide Kidney Int 76 2009 437 444
13. M. Navab, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nat Rev Cardiol 8 2011 222 232
14. T. Tsutsui, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, M. Ohnishi, and M. Kinoshita Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure J Am Coll Cardiol 39 2002 957 962
15. W.H. Tang, Y. Wu, S. Mann, M. Pepoy, K. Shrestha, A.G. Borowski, and S.L. Hazen Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure Circ Heart Fail 4 2011 59 64
16. M.N. Zairis, A.G. Lyras, G.P. Bibis, N.G. Patsourakos, S.S. Makrygiannis, A.D. Kardoulas, M.P. Glyptis, A.A. Prekates, D.V. Cokkinos, and S.G. Foussas Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction Atherosclerosis 182 2005 161 167
17. M. Kosuge, T. Ebina, T. Ishikawa, K. Hibi, K. Tsukahara, J. Okuda, N. Iwahashi, H. Ozaki, H. Yano, I. Kusama, T. Nakati, S. Umemura, and K. Kimura Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes Circ J 71 2007 186 190
18. T.M. Forte, G. Subbanagounder, J.A. Berliner, P.J. Blanche, A.O. Clermont, Z. Jia, M.N. Oda, R.M. Krauss, and J.K. Bielicki Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice J Lipid Res 43 2002 477 485
19. M. Navab, S.T. Reddy, G.M. Anantharamaiah, G. Hough, G.M. Buga, J. Danciger, and A.M. Fogelman D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice J Lipid Res 53 2012 437 445
20. H.M. Den Ruijter, R. Franssen, A.O. Verkerk, D.F. van Wijk, S.F. Vaessen, A.G. Holleboom, J.H. Levels, T. Opthof, R. Sungnoon, E.S. Stroes, J.A. Kuivenhoven, and R. Coronel Reconstituted high-density lipoprotein shortens cardiac repolarization J Am Coll Cardiol 58 2011 40 44